These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 23942540)
1. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Albani F; Riva R; Candela C; Mohamed S; Baruzzi A Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540 [TBL] [Abstract][Full Text] [Related]
2. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs. Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Albani F; Riva R; Baruzzi A Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066 [TBL] [Abstract][Full Text] [Related]
4. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Riva R; Albani F; Avoni P; Baruzzi A Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability. Svendsen T; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI; Johannessen Landmark C Neurochem Res; 2017 Jul; 42(7):2077-2083. PubMed ID: 28349359 [TBL] [Abstract][Full Text] [Related]
6. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
7. Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice. Shandra A; Shandra P; Kaschenko O; Matagne A; Stöhr T Epilepsia; 2013 Jul; 54(7):1167-75. PubMed ID: 23750855 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ; Kelly K; Parker P; Brodie MJ Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [TBL] [Abstract][Full Text] [Related]
9. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures. Gidal BE; Ferry J; Majid O; Hussein Z Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853 [TBL] [Abstract][Full Text] [Related]
10. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
12. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine. Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245 [TBL] [Abstract][Full Text] [Related]
13. A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy. Greenaway C; Ratnaraj N; Sander JW; Patsalos PN Ther Drug Monit; 2010 Aug; 32(4):448-52. PubMed ID: 20386357 [TBL] [Abstract][Full Text] [Related]
14. Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages. May TW; Helmer R; Bien CG; Brandt C Ther Drug Monit; 2018 Oct; 40(5):620-627. PubMed ID: 30086089 [TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication. May TW; Rambeck B; Neb R; Jürgens U Ther Drug Monit; 2007 Dec; 29(6):789-94. PubMed ID: 18043477 [TBL] [Abstract][Full Text] [Related]
16. Comparison of lacosamide concentrations in cerebrospinal fluid and serum in patients with epilepsy. May TW; Brandt C; Helmer R; Bien CG; Cawello W Epilepsia; 2015 Jul; 56(7):1134-40. PubMed ID: 25988882 [TBL] [Abstract][Full Text] [Related]
17. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy. Contin M; Riva R; Albani F; Baruzzi AA Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819 [TBL] [Abstract][Full Text] [Related]
18. Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions--first clinical experience. Sattler A; Schaefer M; May TW; Rambeck B; Brandt C Epilepsy Res; 2011 Aug; 95(3):207-12. PubMed ID: 21543186 [TBL] [Abstract][Full Text] [Related]
20. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort. McGinnis E; Kessler SK Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]